1.08
price down icon3.57%   -0.04
after-market 시간 외 거래: 1.08
loading
전일 마감가:
$1.12
열려 있는:
$1.14
하루 거래량:
1.28M
Relative Volume:
0.74
시가총액:
$103.48M
수익:
-
순이익/손실:
$-93.61M
주가수익비율:
-0.5118
EPS:
-2.11
순현금흐름:
$-71.16M
1주 성능:
+15.93%
1개월 성능:
+54.29%
6개월 성능:
+10.15%
1년 성능:
-25.52%
1일 변동 폭
Value
$1.06
$1.18
1주일 범위
Value
$0.9334
$1.18
52주 변동 폭
Value
$0.561
$2.11

Immunic Inc Stock (IMUX) Company Profile

Name
명칭
Immunic Inc
Name
전화
(332) 255-9818
Name
주소
1200 AVENUE OF THE AMERICAS, NEW YORK
Name
직원
90
Name
트위터
@ImmunicInc
Name
다음 수익 날짜
2025-03-17
Name
최신 SEC 제출 서류
Name
IMUX's Discussions on Twitter

IMUX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IMUX
Immunic Inc
1.08 107.32M 0 -93.61M -71.16M -2.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Immunic Inc Stock (IMUX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-25 개시 William Blair Outperform
2024-11-25 개시 H.C. Wainwright Buy
2024-09-09 재개 Leerink Partners Outperform
2024-08-27 개시 B. Riley Securities Buy
2022-10-21 다운그레이드 SVB Leerink Outperform → Mkt Perform
2022-09-19 재개 H.C. Wainwright Buy
2021-04-15 개시 Aegis Capital Buy
2021-03-24 개시 JMP Securities Mkt Outperform
2020-10-02 개시 SVB Leerink Outperform
2020-08-26 개시 Piper Sandler Overweight
2020-08-07 재개 ROTH Capital Buy
2020-07-20 개시 BMO Capital Markets Outperform
2020-06-05 개시 Wedbush Outperform
2020-05-11 개시 H.C. Wainwright Buy
2020-03-25 개시 ROTH Capital Buy
2019-07-11 개시 Chardan Capital Markets Buy
모두보기

Immunic Inc 주식(IMUX)의 최신 뉴스

pulisher
08:19 AM

What is the dividend policy of Immunic Inc. stockBuild wealth with long-term growth strategies - jammulinksnews.com

08:19 AM
pulisher
01:21 AM

What are analysts’ price targets for Immunic Inc. in the next 12 monthsCapitalize on emerging market trends - jammulinksnews.com

01:21 AM
pulisher
Jul 27, 2025

Should I hold or sell Immunic Inc. stock in 2025Triple-digit profit margins - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is it the right time to buy Immunic Inc. stockFree Predictions - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is Immunic Inc. stock expected to show significant growthIdentify safe investments with exceptional yields - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Immunic Inc. a growth stock or a value stockAchieve rapid portfolio growth with smart picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the technical indicators suggesting about Immunic Inc.Free Consultation - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is Immunic Inc. company’s growth strategyBreakthrough profit margins - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

Immunic, Inc.'s (NASDAQ:IMUX) market cap touched US$103m last week, benefiting both individual investors who own 55% as well as institutions - simplywall.st

Jul 26, 2025
pulisher
Jul 25, 2025

Immunic Reports Positive Long-Term Safety, Tolerability Data for Vidofludimus Calcium in MS Trial - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Immunic Inc. stock priceRapid return acceleration - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Immunic Inc. stockRecord-breaking gains - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

How Immunic Inc. stock reacts to Fed policy changesPowerful profit generation - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Immunic Inc. Stock Analysis and ForecastRapid growth opportunities - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

How high can Immunic Inc. stock price go in 2025Accelerated earnings growth - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Is Immunic Inc. a good long term investmentBreakthrough profits - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Immunic, Inc. shares fall 2.01% premarket after AstraZeneca's immune disorder drug succeeds in late-stage trial. - AInvest

Jul 24, 2025
pulisher
Jul 23, 2025

12 Best Penny Stocks Under $1 to Buy Now - Insider Monkey

Jul 23, 2025
pulisher
Jul 22, 2025

World Brain Day: Immunic targets MS with new therapy - Proactive financial news

Jul 22, 2025
pulisher
Jul 17, 2025

IMUX’s Stock Market Puzzle: Piecing Together 2025’s Performance - investchronicle.com

Jul 17, 2025
pulisher
Jul 15, 2025

What makes Immunic Inc. stock price move sharplyValue Pick Scanner - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Immunic Inc. stock performs during market volatilityFree Top Growth Stock Recommendations - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Immunic Inc. stock attracts strong analyst attentionFree Capital Allocation Plans - Newser

Jul 15, 2025

Immunic Inc (IMUX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
자본화:     |  볼륨(24시간):